Valproate v. lithium in the treatment of bipolar disorder in clinical practice: Observational nationwide register-based cohort study

British Journal of Psychiatry

Volumn 199, Issue 1, 2011, Pages 57-63

  Kessing, Lars Vedel ^a   Hellmund, Gunnar ^b   Geddes, John R ^c   Goodwin, Guy M ^c   Andersen, Per Kragh ^b  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; VALPROIC ACID;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CLINICAL PRACTICE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENMARK; DRUG EFFECT; DRUG EFFICACY; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HOSPITAL; OBSERVATIONAL STUDY; REGISTER;

ADULT; AGED; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DENMARK; DRUG SUBSTITUTION; EPIDEMIOLOGIC METHODS; FEMALE; HOSPITALIZATION; HOSPITALS, PSYCHIATRIC; HUMANS; LITHIUM COMPOUNDS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); VALPROIC ACID; YOUNG ADULT;

EID: 79960103037     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.110.084822     Document Type: Article

References (39)

1. Baldessarini R, Henk H, Sklar A, Chang J, Leahy L. Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence. Psychiatr Serv 2008; 59: 1175-83.
2. Pope Jr HG, McElroy SL, Keck Jr PE, Hudson JI. Valproate in the treatment of acute mania. A placebo-controlled study. Arch Gen Psychiatry 1991; 48: 62-8.
3. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA 1994; 271: 918-24. (Pubitemid 24083217)
4. Bowden CL, Swann AC, Calabrese JR, Rubenfaer LM, Wozniak PJ, Collins MA, et al. A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania. J Clin Psychiatry 2006; 67: 1501-10. (Pubitemid 44787431)
5. Bowden C, Gogus A, Grunze H, Haggstrom L, Rybakowski J, Vieta E. A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode. Int Clin Psychopharmacol 2008; 23: 254-62.
6. Freeman TW, Clothier JL, Pazzaglia P, Lesem MD, Swann AC. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry 1992; 149: 108-11.
7. Macritchie K, Geddes JR, Scott J, Haslam D, de LM, Goodwin G. Valproate for acute mood episodes in bipolar disorder. Cochrane Database Syst Rev 2003; 1: CD004052.
8. Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller HJ, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry 2010; 11: 81-109.
9. Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry 2000; 57: 481-9. (Pubitemid 30257262)
10. Geddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani A, Ostacher MJ, et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet 2010; 375: 385-95.
11. Lauer MS, Collins FS. Using science to improve the nation's health system: NIH's commitment to comparative effectiveness research. JAMA 2010; 303: 2182-3.
12. Baldessarini RJ. Treatment research in bipolar disorder: issues and recommendations. CNS Drugs 2002; 16: 721-9. (Pubitemid 35252721)
13. Calabrese JR, Kemp DE. Bipolar drug development: are we getting closer to the real world? Am J Psychiatry 2008; 165: 1234-6.
14. Citrome L. Interpreting and applying the CATIE results: with CATIE, context is key when sorting out Phases 1, 1A, 1B, 2E, and 2T. Psychiatry 2007; 4: 23-9.
15. Licht RW. Limitations in randomised controlled trials evaluating drug effects in mania. Eur Arch Psychiatry Clin Neurosci 2001; 251 (suppl 2): 1166-71.
16. Reed C, Novick D, Gonzalez-Pinto A, Bertsch J, Haro JM. Observational study designs for bipolar disorder - what can they tell us about treatment in acute mania? Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 715-21.
17. Malig C. The Civil Registration System in Denmark. (IIVRS Technical Paper no. 66). International Institute for Vital Registration and Statistics, 1996.
18. Munk-Jorgensen P, Mortensen PB. The Danish Psychiatric Central Register. Dan Med Bull 1997; 44: 82-4. (Pubitemid 27110215)
19. Danish National Board of Health, L. Medicinal Product Statistics. Danish National Board of Health, 2002 (http://www.laegemiddelstyrelsen.dk).
20. Juel K, Helweg-Larsen K. The Danish registers of causes of death. Dan Med Bull 1999; 46: 354-7. (Pubitemid 29439149)
21. Andersen TF, Madsen M, Jorgensen J, Mellemkjaer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999; 46: 263-8.
22. World Health Organization. Klassifikation af Sygdomme. Systematisk Del. [International Statistical Classification of Diseases and Health Related Problems (10th revision, Danish edn)]. Munksgaard, Copenhagen, 1993.
23. WHO Collaborating Centre for Drug Statistics Methodology. ATC index with DDDs. WHO Collaborating Centre for Drug Statistics Methodology, 2003.
24. Kessing LV, Sondergard L, Kvist K, Andersen PK. Suicide risk in patients treated with lithium. Arch Gen Psychiatry 2005; 62: 860-6. (Pubitemid 41126880)
25. Müller-Oerlinghausen B, Berghofer A, Ahrens B. The antisuicidal and mortality-reducing effect of lithium prophylaxis: consequences for guidelines in clinical psychiatry. Can J Psychiatry 2003; 48: 433-9. (Pubitemid 37295200)
26. Schou M. Lithium treatment at 52. J Affect Disord 2001; 67: 21-32. (Pubitemid 34183334)
27. Schou M. Suicidal behavior and prophylactic lithium treatment of major mood disorders: a review of reviews. Suicide Life Threat Behav 2000; 30: 289-93.
28. Licht RW, Vestergaard P, Kessing LV, Larsen JK, Thomsen PH. Psychopharmacological treatment with lithium and antiepileptic drugs: suggested guidelines from the Danish Psychiatric Association and the Child and Adolescent Psychiatric Association in Denmark. Acta Psychiatr Scand Suppl 2003; 419: 1-22. (Pubitemid 37297197)
29. Goodwin GM, Geddes JR. Latest maintenance data on lithium in bipolar disorder. Eur Neuropsychopharmacol 2003; 13 (suppl 2): S51-5.
30. Coryell W. Maintenance treatment in bipolar disorder: a reassessment of lithium as the first choice. Bipolar Disord 2009; 11 (suppl 2): 77-83.
31. Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry 2009; 10: 85-116.
32. Partonen T, Sihvo S, Lonnqvist JK. Patients excluded from an antidepressant efficacy trial. J Clin Psychiatry 1996; 57: 572-5. (Pubitemid 27056898)
33. Keitner GI, Posternak MA, Ryan CE. How many subjects with major depressive disorder meet eligibility requirements of an antidepressant efficacy trial? J Clin Psychiatry 2003; 64: 1091-3.
34. Zimmerman M, Mattia JI, Posternak MA. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? Am J Psychiatry 2002; 159: 469-73.
35. Kleindienst N, Severus WE, Moller HJ, Greil W. Is polarity of recurrence related to serum lithium level in patients with bipolar disorder? Eur Arch Psychiatry Clin Neurosci 2005; 255: 72-4.
36. Licht RW. A new BALANCE in bipolar I disorder. Lancet 2010; 375: 350-2.
37. Cipriani A, Pretty H, Hawton K, Geddes JR. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry 2005; 162: 1805-19. (Pubitemid 41428610)
38. Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 2003; 290: 1467-73. (Pubitemid 37430401)
39. Sondergard L, Lopez AG, Andersen PK, Kessing LV. Mood-stabilizing pharmacological treatment in bipolar disorders and risk of suicide. Bipolar Disord 2008; 10: 87-94.